Overview

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Status:
Terminated
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if addition of abatacept is safe and improves the effectiveness of treatment of patients with active lupus nephritis who are also taking mycophenolate mofetil (MMF) and corticosteroids.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Abatacept
Mycophenolate mofetil
Mycophenolic Acid
Prednisolone
Prednisone